Role of endogenous glucagon-like peptide-1 in the serum triglyceride response to intraduodenal fat infusion in type 2 diabetic patients on vildagliptin

被引：0
|
作者：
Wu, T. [1 ,2 ]
Xie, C. [1 ]
Wang, X. [1 ,2 ]
Bound, M. J. [1 ]
Grivell, J. [1 ]
Jones, K. L. [1 ]
Horowitz, M. [1 ]
Little, T. J. [1 ]
Rayner, C. K. [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Southeast Univ, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
579
引用
下载
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [41] A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy
    Fan, Zhixing
    Yang, Chaojun
    Yang, Jian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 : 294 - 295
  • [42] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    MICROCIRCULATION, 2019, 26 (03)
  • [43] Glutamine Reduces Postprandial Glycemia and Augments the Glucagon-Like Peptide-1 Response in Type 2 Diabetes Patients
    Samocha-Bonet, Dorit
    Wong, Olivia
    Synnott, Emma-Leigh
    Piyaratna, Naomi
    Douglas, Ashley
    Gribble, Fiona M.
    Holst, Jens J.
    Chisholm, Donald J.
    Greenfield, Jerry R.
    JOURNAL OF NUTRITION, 2011, 141 (07): : 1233 - 1238
  • [44] Metformin effects on glucagon-like peptide-1 levels in obese diabetic and non diabetic patients
    Mannucci, E
    Bardini, G
    Tesi, F
    Ognibene, A
    Petracca, MG
    Ciani, S
    Brogi, M
    Cremasco, F
    Messeri, G
    Rotella, CM
    DIABETOLOGIA, 2002, 45 : A217 - A217
  • [45] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Adam M Deane
    Matthew J Summers
    Antony V Zaknic
    Marianne J Chapman
    Robert JL Fraser
    Anna E Di Bartolomeo
    Judith M Wishart
    Michael Horowitz
    Critical Care, 15
  • [46] Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
    Deane, Adam M.
    Summers, Matthew J.
    Zaknic, Antony V.
    Chapman, Marianne J.
    Fraser, Robert J. L.
    Di Bartolomeo, Anna E.
    Wishart, Judith M.
    Horowitz, Michael
    CRITICAL CARE, 2011, 15 (01):
  • [47] The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
    Shestakova, M. V.
    DIABETES MELLITUS, 2010, 13 (03): : 106 - 109
  • [48] Endogenous glucagon-like peptide-1 system response is impaired during ST-elevation myocardial infarction in type 2 diabetes patients
    Elbaz-Greener, Gabby
    Bloch, Olga
    Kumets, Ilya
    Blatt, Alex
    Rapoport, Micha J.
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 194 - 198
  • [49] The role of glucagon-like peptide-1 to stimulate postprandial insulin secretion in type 2 diabetes
    Salehi, Marzieh
    Aulinger, Benedikt A.
    D'Alessio, David A.
    DIABETES, 2007, 56 : A385 - A386
  • [50] Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetes
    Kramer, Caroline K.
    Zinman, Bernard
    Choi, Haysook
    Connelly, Philip W.
    Retnakaran, Ravi
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 744 - 748
12345